✦ On Aug. 7, BioScrip, Inc. and Option Care revealed that their merger was complete (RSP 4/19, p. 1). The new company is known as Option Care Health, Inc. On July 30, BioScrip reported a second- quarter 2019 net loss of $15.7 million, or 14 cents per share, compared with a net loss of $15.1 million, or 14 cents per share, in the prior-year period. The infusion services firm had revenue of $191.5 million for the most recent quarter, up 8.9% from $175.8 million in the second quarter of 2018. The company also disclosed that Option Care had a net loss for the quarter of $13.6 million, compared with a net loss of $4.3 million for the prior-year period. It also had revenue of $512.6 million, up 3.2% from $496.9 million in second-quarter 2018.